81_FR_54263 81 FR 54106 - National Institute on Drug Abuse; Notice of Meeting

81 FR 54106 - National Institute on Drug Abuse; Notice of Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 81, Issue 157 (August 15, 2016)

Page Range54106-54106
FR Document2016-19279

Federal Register, Volume 81 Issue 157 (Monday, August 15, 2016) 
[Federal Register Volume 81, Number 157 (Monday, August 15, 2016)]
[Notices]
[Page 54106]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-19279]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a meeting of the 
National Advisory Council on Drug Abuse.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and/or contract proposals 
and the discussions could disclose confidential trade secrets or 
commercial property such as patentable material, and personal 
information concerning individuals associated with the grant 
applications and/or contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Advisory Council on Drug Abuse.
    Date: September 8, 2016.
    Closed: 9:00 a.m. to 10:30 a.m.
    Agenda: To review and evaluate grant applications and/or 
proposals.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852.
    Open: 11:00 a.m. to 4:15 p.m.
    Agenda: This portion of the meeting will be open to the public 
for announcements and reports of administrative, legislative, and 
program developments in the drug abuse field.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852.
    Contact Person: Susan R.B. Weiss, Ph.D., Director, Division of 
Extramural Research, Office of the Director, National Institute on 
Drug Abuse, NIH, DHHS, 6001 Executive Boulevard, NSC, Room 5274, MSC 
9591, Rockville, MD 20892, 301-443-6487, sweiss@nida.nih.gov.

    Any member of the public interested in presenting oral comments 
to the committee may notify the Contact Person listed on this notice 
at least 10 days in advance of the meeting. Interested individuals 
and representatives of organizations may submit a letter of intent, 
a brief description of the organization represented, and a short 
description of the oral presentation. Only one representative of an 
organization may be allowed to present oral comments and if accepted 
by the committee, presentations may be limited to five minutes. Both 
printed and electronic copies are requested for the record. In 
addition, any interested person may file written comments with the 
committee by forwarding their statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    Information is also available on the Institute's/Center's home 
page: www.drugabuse.gov/NACDA/NACDAHome.html, where an agenda and 
any additional information for the meeting will be posted when 
available.

(Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug 
Abuse and Addiction Research Programs, National Institutes of 
Health, HHS)

    Dated: August 9, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-19279 Filed 8-12-16; 8:45 am]
 BILLING CODE 4140-01-P

54106 Federal Register / Vol. 81, No. 157 / Monday, August 15, 2016 / Notices Dated: August 9, 2016. Any member of the public interested in Date: September 8, 2016. Michelle Trout, presenting oral comments to the committee Time: 1:00 p.m. to 2:30 p.m. may notify the Contact Person listed on this Agenda: To review and evaluate contract Program Analyst, Office of Federal Advisory notice at least 10 days in advance of the proposals. Committee Policy. meeting. Interested individuals and Place: National Institutes of Health, [FR Doc. 2016–19277 Filed 8–12–16; 8:45 am] representatives of organizations may submit National Institute on Alcohol Abuse and BILLING CODE 4140–01–P a letter of intent, a brief description of the Alcoholism, 5635 Fishers Lane, Bethesda, organization represented, and a short MD 20892 (Telephone Conference Call). description of the oral presentation. Only one Contact Person: Ranga V. Srinivas, Ph.D., DEPARTMENT OF HEALTH AND representative of an organization may be Chief, Extramural Project Review Branch, HUMAN SERVICES allowed to present oral comments and if National Institute on Alcohol Abuse and accepted by the committee, presentations Alcoholism, National Institutes of Health, National Institutes of Health may be limited to five minutes. Both printed 5365 Fishers Lane, Room 2085, Rockville, and electronic copies are requested for the MD 20852, (301) 451–2067, srinivar@ record. In addition, any interested person mail.nih.gov. National Institute on Drug Abuse; Notice of Meeting may file written comments with the Name of Committee: National Institute on committee by forwarding their statement to Alcohol Abuse and Alcoholism Special Pursuant to section 10(d) of the the Contact Person listed on this notice. The Emphasis Panel; NIAAA/NIDA Joint T32 Federal Advisory Committee Act, as statement should include the name, address, Training Review. telephone number and when applicable, the Date: October 27–28, 2016. amended (5 U.S.C. App.), notice is business or professional affiliation of the Time: 8:00 a.m. to 5:00 p.m. hereby given of a meeting of the interested person. Agenda: To review and evaluate grant National Advisory Council on Drug Information is also available on the applications. Abuse. Institute’s/Center’s home page: Place: Courtyard by Marriott Chevy Chase, The meeting will be open to the www.drugabuse.gov/NACDA/ 5520 Wisconsin Avenue, Chevy Chase, MD public as indicated below, with NACDAHome.html, where an agenda and 20815. attendance limited to space available. any additional information for the meeting Contact Persons: Richard A. Rippe, Ph.D., Individuals who plan to attend and will be posted when available. Scientific Review Officer, National Institute (Catalogue of Federal Domestic Assistance on Alcohol Abuse and Alcoholism, National need special assistance, such as sign Institutes of Health, 5635 Fishers Lane, Room language interpretation or other Program Nos.: 93.279, Drug Abuse and Addiction Research Programs, National 2109, Rockville, MD 20852, 301–443–8599, reasonable accommodations, should Institutes of Health, HHS) rippera@mail.nih.gov. notify the Contact Person listed below Susan O. McGuire, Ph.D., Scientific in advance of the meeting. Dated: August 9, 2016. Review Officer, Office of Extramural Policy The meeting will be closed to the Natasha M. Copeland, and Review, Division of Extramural public in accordance with the Program Analyst, Office of Federal Advisory Research, National Institute on Drug Abuse, provisions set forth in sections Committee Policy. National Institutes of Health, 6001 Executive Boulevard, Room 4245, Bethesda, MD 20892, 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., [FR Doc. 2016–19279 Filed 8–12–16; 8:45 am] 301–827–5817, susan.mcguire@nih.gov. as amended. The grant applications BILLING CODE 4140–01–P (Catalogue of Federal Domestic Assistance and/or contract proposals and the Program Nos. 93.271, Alcohol Research discussions could disclose confidential Career Development Awards for Scientists trade secrets or commercial property DEPARTMENT OF HEALTH AND and Clinicians; 93.272, Alcohol National such as patentable material, and HUMAN SERVICES Research Service Awards for Research personal information concerning Training; 93.273, Alcohol Research Programs; individuals associated with the grant National Institutes of Health 93.891, Alcohol Research Center Grants; applications and/or contract proposals, 93.701, ARRA Related Biomedical Research National Institute on Alcohol Abuse and Research Support Awards, National the disclosure of which would and Alcoholism; Notice of Closed Institutes of Health, HHS) constitute a clearly unwarranted Meeting Dated: August 9, 2016. invasion of personal privacy. Pursuant to section 10(d) of the Melanie J. Gray, Name of Committee: National Advisory Council on Drug Abuse. Federal Advisory Committee Act, as Program Analyst, Office of Federal Advisory Date: September 8, 2016. amended (5 U.S.C. App.), notice is Committee Policy. Closed: 9:00 a.m. to 10:30 a.m. hereby given of the following meeting. [FR Doc. 2016–19276 Filed 8–12–16; 8:45 am] Agenda: To review and evaluate grant The meeting will be closed to the BILLING CODE 4140–01–P applications and/or proposals. public in accordance with the Place: National Institutes of Health, provisions set forth in sections Neuroscience Center, 6001 Executive 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., DEPARTMENT OF HEALTH AND Boulevard, Rockville, MD 20852. as amended. The grant applications/ HUMAN SERVICES Open: 11:00 a.m. to 4:15 p.m. Agenda: This portion of the meeting will contract proposals and the discussions could disclose confidential trade secrets National Institutes of Health be open to the public for announcements and reports of administrative, legislative, and or commercial property such as patentable material, and personal National Heart, Lung, and Blood program developments in the drug abuse field. information concerning individuals Institute; Notice of Closed Meeting Place: National Institutes of Health, associated with the grant applications/ Pursuant to section 10(d) of the Neuroscience Center, 6001 Executive contract proposals, the disclosure of sradovich on DSK3GMQ082PROD with NOTICES Federal Advisory Committee Act, as Boulevard, Rockville, MD 20852. which would constitute a clearly amended (5 U.S.C. App.), notice is Contact Person: Susan R.B. Weiss, Ph.D., unwarranted invasion of personal Director, Division of Extramural Research, hereby given of the following meeting. Office of the Director, National Institute on privacy. The meeting will be closed to the Drug Abuse, NIH, DHHS, 6001 Executive Name of Committee: National Institute on public in accordance with the Boulevard, NSC, Room 5274, MSC 9591, Alcohol Abuse and Alcoholism Special provisions set forth in sections Rockville, MD 20892, 301–443–6487, Emphasis Panel; NIAAA Contract Proposals 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., sweiss@nida.nih.gov. Topic 015, PHS 2016–1. as amended. The contract proposals and VerDate Sep<11>2014 19:23 Aug 12, 2016 Jkt 238001 PO 00000 Frm 00066 Fmt 4703 Sfmt 4703 E:\FR\FM\15AUN1.SGM 15AUN1


Document Created: 2016-08-13 02:22:15
Document Modified: 2016-08-13 02:22:15
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesSeptember 8, 2016.
FR Citation81 FR 54106 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR